LAURA GILLESPIE: Open Payments
NPI 1154318418 · MT JULIET, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,431 in 76 payments from 15 companies in 2025. Trend: 2023 $1,840 · 2024 $903 · 2025 $1,431
Food & beverage: $1,431
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $350 |
| AstraZeneca Pharmaceuticals LP | 10 | $236 |
| ABBVIE INC. | 15 | $155 |
| GlaxoSmithKline, LLC. | 8 | $150 |
| Lilly USA, LLC | 10 | $150 |
| Exact Sciences Corporation | 4 | $68 |
| Astellas Pharma US Inc | 3 | $67 |
| PFIZER INC. | 3 | $61 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $46 |
| Amgen Inc. | 2 | $31 |
Products named: Ozempic, AIRSUPRA, Wegovy, MOUNJARO, SHINGRIX, UBRELVY, BREZTRI, TRELEGY ELLIPTA.
Industry payments across TN — which companies pay providers there.
